OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures
Sofie Meulewaeter, Gust Nuytten, Miffy H. Y. Cheng, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 149-160
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53

Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity
Heyang Zhang, Jo Vandesompele, Kevin Braeckmans, et al.
Chemical Society Reviews (2023) Vol. 53, Iss. 1, pp. 317-360
Closed Access | Times Cited: 30

Exploiting Unique Features of Microneedles to Modulate Immunity
Camilla Edwards, Shrey Shah, Thomas Gebhardt, et al.
Advanced Materials (2023) Vol. 35, Iss. 52
Open Access | Times Cited: 22

Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends
Mariana Biscaia-Caleiras, Nuno A. Fonseca, Ana Sofia Lourenço, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 617-639
Closed Access | Times Cited: 13

Overcoming thermostability challenges in mRNA–lipid nanoparticle systems with piperidine-based ionizable lipids
Kazuki Hashiba, Masamitsu Taguchi, Sachiko Sakamoto, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 10

Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics
Paula Gil-Cabrerizo, Teresa Simón‐Yarza, Elisa Garbayo, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115302-115302
Open Access | Times Cited: 9

A perspective on bleb and empty LNP structures
Jens B Simonsen
Journal of Controlled Release (2024) Vol. 373, pp. 952-961
Closed Access | Times Cited: 9

Advances in the design and delivery of RNA vaccines for infectious diseases
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 7

Process development and quality attributes for the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanomedicine delivery: a state-of-the-art review
Sagar R. Pardeshi, Nilesh S. Deshmukh, Darshan R. Telange, et al.
Future Journal of Pharmaceutical Sciences (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 20

Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing
Maryam Youssef, Cynthia Hitti, Julia Puppin Chaves Fulber, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1497-1497
Open Access | Times Cited: 17

Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines
Bin Zhang, Wei Kian Sim, Tang‐Long Shen, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 6

Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines
Yeung Wu, Sinuo Yu, Irene de Lázaro
Nanoscale (2024) Vol. 16, Iss. 14, pp. 6820-6836
Closed Access | Times Cited: 6

Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria
Sofie Meulewaeter, Ilke Aernout, Joke Deprez, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 379-391
Open Access | Times Cited: 6

Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size
Ruimeng Shi, Xueli Liu, Yajuan Wang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 6

Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy
Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi
Journal of Controlled Release (2024) Vol. 372, pp. 113-140
Closed Access | Times Cited: 6

Development of ionizable lipid nanoparticles and a lyophilized formulation for potent CRISPR-Cas9 delivery and genome editing
Qian Sun, Hongqian Zhang, Feng Ding, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123845-123845
Closed Access | Times Cited: 5

Formulation screening of lyophilized mRNA-lipid nanoparticles
Anna Ruppl, Denis Kiesewetter, Monika Koell-Weber, et al.
International Journal of Pharmaceutics (2025), pp. 125272-125272
Open Access

Advances in Lipid Nanoparticle‐Based Disease Treatment
Yujie Zhou, Qiqi Ge, Xin Wang, et al.
ChemMedChem (2025)
Closed Access

mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious Diseases
Saeideh Khorshid Sokhangouy, Mohammad Amin Behzadi, Samira Rezaei, et al.
Biotechnology Journal (2025) Vol. 20, Iss. 2
Closed Access

Manganese-Loaded pH-Responsive DNA Hydrogels Enable Tg-Guided Thyroid Tumor Targeted Magnetic Resonance Imaging
Qingyi Hu, Anwen Ren, Ximeng Zhang, et al.
ACS Applied Materials & Interfaces (2025) Vol. 17, Iss. 9, pp. 13403-13414
Open Access

Lyophilized monkeypox mRNA lipid nanoparticle vaccines with long-term stability and robust immune responses in mice
Bin Wang, Quanyi Yin, Yi Li, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access

Physicochemical and structural insights into lyophilized mRNA-LNP from lyoprotectant and buffer screenings
Yuchen Fan, Diamanda Rigas, Lee Joon Kim, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 727-737
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top